The inhibitory effect of ursodeoxycholic acid and pentoxifylline on platelet derived growth factor-stimulated proliferation is distinct from an effect by cyclic AMP-Reference-Cited by-同舟云学术

The inhibitory effect of ursodeoxycholic acid and pentoxifylline on platelet derived growth factor-stimulated proliferation is distinct from an effect by cyclic AMP

Published:1998-06 Issue:3 Volume:39 Page:181-191
ISSN:0162-3109
Container-title:Immunopharmacology
language:en
Short-container-title:Immunopharmacology

Author:

Peterson Theresa C.,Slysz Gordon,Isbrucker Richard

Publisher

Elsevier BV

Subject

Pharmacology

Reference44 articles.

1. Inhibitory effect of sodium ursodeoxycholate on basal and stimulated short circuit current across the isolated toad skin;Alonso;Comp. Biochem. Physiol., Pharmacol. Toxicol. Endocrinol.,1995

2. Alteration of cyclic AMP mediated hormonal responsiveness by bile acids in cells of a non hepatic origin;Bouscarel;American Journal of Physiology,1996

3. Differential effects of chenodeoxycholic and ursodeoxycholic acids in interleukin 1, interleukin 6 and tumor necrosis factor-α production by monocytes;Calmus;Hepatology,1992

4. Composition of several mammalian biles and their membrane damaging properties;Coleman;Biochem. J.,1979

5. Effect of ingested pentoxifylline on neutrophil superoxide anion production;Crouch;Infect. Immun.,1992

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Experience of Analyzing Biological Activity of Ursodeoxycholic Acid as Part of In Silico Prediction of the Gene Expression Profile;Russian Journal of Genetics;2020-10

2. Xanthines and Phosphodiesterase Inhibitors;Handbook of Experimental Pharmacology;2016

3. Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode;International Journal of Molecular Sciences;2012-07-17

4. A novel drug interaction between the quinolone antibiotic ciprofloxacin and a chiral metabolite of pentoxifylline;Biochemical Pharmacology;2007-08

5. Metabolic, antioxidant, nutraceutical, probiotic, and herbal therapies relating to the management of hepatobiliary disorders;Veterinary Clinics of North America: Small Animal Practice;2004-01